Internal Medicine, Nephrology · Fort Collins, CO
NPI
1144549007
Since 2010
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1600 Specht Point Rd Ste 127
Fort Collins, CO, 80525
Phone (970) 493-7733
Groups this clinician bills Medicare through
Medicare paid, 2024
$149K
1,469 services
Medicare patients, 2024
479
Average age 73
Drug cost, 2024
$165K
2,178 prescriptions
Company payments, 2025
$21.3
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara T Burgardt was code 99214 (office e&m - established), 264 times for 209 patients. In total Sara T Burgardt billed 1,469 services in 26 codes, and Medicare paid $149K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 264 | 209 | $74.95 | $20K |
| 90960 ESRD Related Services (not dialysis) | Office | 190 | 36 | $287.88 | $55K |
| 99233 Hospital E&M - Subsequent | Facility | 124 | 69 | $93.04 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 97 | 95 | $12.70 | $1,232 |
| 90961 ESRD Related Services (not dialysis) | Office | 92 | 38 | $240.61 | $22K |
| 90935 Hemodialysis | Facility | 88 | 55 | $53.58 | $4,715 |
| 99232 Hospital E&M - Subsequent | Facility | 75 | 52 | $62.32 | $4,674 |
| 99215 Office E&M - Established | Office | 68 | 60 | $89.85 | $6,110 |
| 99213 Office E&M - Established | Office | 52 | 49 | $47.82 | $2,487 |
| 81002 Clinical Chemistry | Office | 43 | 43 | $3.41 | $147 |
| 99291 Critical Care E&M | Facility | 38 | 29 | $162.45 | $6,173 |
| 99223 Hospital E&M - Initial | Facility | 32 | 31 | $137.06 | $4,386 |
| 99205 Office E&M - New | Office | 22 | 22 | $171.96 | $3,783 |
| 99204 Office E&M - New | Office | 18 | 18 | $127.48 | $2,295 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $103.31 | $1,136 |
By year: 2022 $170K for 1,376 services; 2023 $157K for 1,347 services; 2024 $149K for 1,469 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 43 | 43 | $3.41 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Sara T Burgardt prescribed most often to Medicare patients was Carvedilol, with 193 prescriptions and refills. In total Sara T Burgardt wrote 2,178 Medicare prescriptions that cost $165K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 193 | 512 | 60 | $1,602 |
| Losartan Potassium Generic | 135 | 358 | 35 | $1,303 |
| Amlodipine Besylate Generic | 128 | 333 | 40 | $790 |
| Lisinopril Generic | 116 | 329 | 34 | $975 |
| Furosemide Generic | 106 | 297 | 37 | $650 |
| Allopurinol Generic | 103 | 289 | 31 | $849 |
| Amiloride Hcl Generic | 89 | 219 | 23 | $1,562 |
| Potassium Chloride Generic | 77 | 171 | 22 | $1,564 |
| Bumetanide Generic | 77 | 207 | 32 | $3,889 |
| Hydrochlorothiazide Generic | 59 | 143 | 15 | $292 |
| Hydralazine Hcl Generic | 57 | 142 | 22 | $867 |
| Tamsulosin Hcl Generic | 55 | 131 | 13 | $1,087 |
| Calcitriol Generic | 51 | 131 | 18 | $598 |
| Spironolactone Generic | 48 | 128 | 16 | $364 |
| Prednisone Generic | 48 | 114 | 15 | $327 |
Brand drugs: - claims; generic drugs: 1,932 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sara T Burgardt $21.3 ($21.3 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $21.3.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $21.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.